Dataset Information

Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis.

ABSTRACT: Insertion and deletion variants (indels) within poly glycine tracts of fused in sarcoma (FUS) were initially reported as causative of disease in amyotrophic lateral sclerosis (ALS). Subsequent studies identified similar indels in controls and suggested that these indels may confer susceptibility to ALS. We aimed to elucidate the role of previously published and novel exonic indels in FUS in an extensive cohort of 630 ALS patients and 1063 controls. We detected indels in FUS exons 5, 6, 12, and 14 with similar frequencies in patients (0.95%) and controls (0.75%). Exonic indels in poly glycine tracts were also observed with similar frequencies. The largest indel (p.Gly138_Tyr143del) was observed in 1 control. In 1 patient, a 3 base pair deletion in exon 14 (p.Gly475del) was identified, however in vitro studies did not reveal abnormal localization of p.Gly475del mutant FUS. These findings suggest that not all exonic indels in FUS cause disease.

SUBMITTER: Rutherford NJ

PROVIDER: S-EPMC3130814 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis.

Rutherford Nicola J NJ Finch Nicole A NA DeJesus-Hernandez Mariely M Crook Richard J P RJ Lomen-Hoerth Catherine C Wszolek Zbigniew K ZK Uitti Ryan J RJ Graff-Radford Neill R NR Rademakers Rosa R

Neurobiology of aging 20101112 2

Insertion and deletion variants (indels) within poly glycine tracts of fused in sarcoma (FUS) were initially reported as causative of disease in amyotrophic lateral sclerosis (ALS). Subsequent studies identified similar indels in controls and suggested that these indels may confer susceptibility to ALS. We aimed to elucidate the role of previously published and novel exonic indels in FUS in an extensive cohort of 630 ALS patients and 1063 controls. We detected indels in FUS exons 5, 6, 12, and 1 ...[more]

PMID: 21074900

Dataset Information

Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis.

Publications

Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis.
| S-EPMC11312655 | biostudies-literature

Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models.
| S-EPMC8413276 | biostudies-literature

Targeting TNFα produced by astrocytes expressing amyotrophic lateral sclerosis-linked mutant fused in sarcoma prevents neurodegeneration and motor dysfunction in mice.
| S-EPMC9540310 | biostudies-literature

Amyotrophic lateral sclerosis.
| S-EPMC10089700 | biostudies-literature

Molecular dynamics and protein frustration analysis of human fused in Sarcoma protein variants in Amyotrophic Lateral Sclerosis type 6: An In Silico approach.
| S-EPMC8480726 | biostudies-literature

Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes.
| S-EPMC2117704 | biostudies-literature

Destination Amyotrophic Lateral Sclerosis.
| S-EPMC8039771 | biostudies-literature